Search This Blog

Sunday, January 7, 2024

Shribman: The New Hampshire pri­mary could push Mr. Biden out of of­fice

 There is a phony political contest going on here, just below the radar, that Joe Biden can only lose. He almost certainly won’t, but there’s danger anyhow in the companion to the bruising New Hampshire Primary where four Republicans are desperately trying to defeat a former president, Donald Trump, but probably won’t.

Mr. Biden’s allies — mostly establishment Democratic figures, some of whom might welcome his withdrawal — are ramping up a write-in campaign to permit him to prevail in a contest that he says shouldn’t matter and that he took steps to insure wouldn’t matter — unless of course he loses.

Biden’s risky choice

Months ago the president, who finished fifth here in 2000, ordered Democrats to begin their primary contests in South Carolina rather than New Hampshire, which has held the first primary for more than a century. Thus the results of this month’s contest won’t count in the struggle for delegates at the Democratic convention.

But he, or rather his surrogates, are competing anyway. Just the other day, Governor J.B. Pritzker of Illinois — ssshhhh! He might run for president if Mr. Biden demurs — sent out an appeal to Democrats arguing this write-in campaign was “truly, vitally important.”

This is a big risk, even if his opponents are the self-help author Marianne Williamson and little-known Representative Dean Phillips of Minnesota. Because New Hampshire will allow pretty much anyone to vote in the GOP primary, Trump opponents might be happier casting a ballot for former Governor Nikki Haley than a meaningless write-in for Mr. Biden.

And then there is the 1968 flashing caution light.

President Lyndon Johnson didn’t compete in New Hampshire, but a similar write-in campaign was underway anyway. His team was worried enough to conduct private polls that suggested his lone opponent, Senator Eugene McCarthy of Minnesota, might manage 18%. “I never allowed my name to go on the ticket in New Hampshire,” the president said later in an oral history for his presidential library. “If I had, I have no doubt that I would have won New Hampshire two to one.”

But he didn’t, and he didn’t.

Mr. McCarthy came within 230 votes of defeating Mr. Johnson.

There was trouble for LBJ from the start. “He had never spent a winter’s morning standing outside the Brown Paper Company in Berlin greeting workers arriving for their shift,” Charles Brereton wrote in his 1987 book “First in the Nation.” “Nor had he ever strolled up and down a Main Street greeting shoppers or merchants.”

Two days before the primary, Mr. Johnson bid Lady Bird to their bedroom. He had gone for a nap but couldn’t sleep. Maybe it was because of the conversation the couple had had earlier in the day. She asked him, not in a querulous but in a curious way, “Suppose someone else were elected president, what could “Mr. X’ do that you could not do?”

Mr. Johnson’s answer: “He could unite the country and start getting some things done. That would last about a year, maybe two years.”

In her diary, Mrs. Johnson engaged in deep reflection. “I think that is what weighs heaviest on Lyndon’s mind. Can he unite the country, or is there simply too much built-up antagonism, division, a general malaise, which may have the Presidency — or this President — irrevocably as its focal point?”

Johnson’s hard decision

A month earlier, U.S. News and World Report said that “At this point, there is just one near certainty about the ‘68 elections … Lyndon Johnson, health permitting, will be the Democratic nominee.” Chicago Daily News columnist Carl Rowan wrote at about the same time that the chances that the president wouldn’t run “can’t be better than a million to one.”

The Johnsons — husband and wife, daughters Lynda and Luci — had discussed the trajectory of the presidency frequently, repeatedly vetting the question of whether they might leave the White House at the end of Mr. Johnson’s first term, in January 1969. Mrs. Johnson was clear-eyed about it; one full term was enough. Luci worried about her father’s health. Lynda preferred that he demur.

As early as September 1967, 14 months before the election, press secretary George Christian was noodling around with a withdrawal statement. Governor John Connolly was recruited to help.

Mr. Johnson shared his doubts about another term with, among others, Secretary of State Dean Rusk and Secretary of Defense Robert McNamara. The president was preoccupied with the question of whether the American combatants in Vietnam would feel let down. General William Westmoreland assured him they wouldn’t.

Meanwhile, Horace Busby was working on the language the president might use to announce such a decision, perhaps during his State of the Union Address. Many years ago, Mr. Busby, who had become a very good source of mine, told me that he wasn’t sure whether Mr. Johnson would use that occasion. In the event, the president forgot to bring the statement with him to the Capitol.

On March 31, in a nationally televised address on Vietnam, he said: “With America’s sons in the fields far away, with America’s future under challenge right here at home, with our hopes and the world’s hopes for peace in the balance every day, I do not believe that I should devote an hour or a day of my time to any personal partisan causes or to any duties other than the awesome duties of this office.”

He said in his memoir: “I had used the power of the Presidency proudly, and I used every ounce of it I had. I used it to establish programs that gave thousands of youngsters a head start in school, that enabled thousands of old folks to live in clean nursing homes, that brought justice to the Negro and hope to the poor, that forced the nation to face the growing problems of pollution.”

Jitters or courage

He continued, in language that might give Mr. Biden jitters, or courage: “In this exercise of power, I knew a satisfaction that only a limited number of men have ever known, and that I could have had in no other way. Men, myself included, do not lightly give up the opportunity to achieve so much lasting good, but a man who uses power effectively must also be a realist. He must understand that by spending power he dissipates it.”

A botched write-in campaign helped nudge Mr. Johnson out of a re-election campaign. It could happen again. It probably won’t, but it could.

David M. Shribman is the former executive editor of the Pittsburgh Post-Gazette.

https://www.post-gazette.com/opinion/david-shribman/2024/01/07/shribman-biden-write-in-lyndon-johnson-new-hampshire/stories/202401050017

Biden Administration withholds funds from noncompliant student loan lenders

 The Biden Administration announced Friday that it is withholding payments to three student loan companies that have failed to comply with their obligations to provide borrowers with "timely billing statements."

Aidvantage, EdFinancial and Nelnet "failed to meet contractual obligations," the Department of Education said in a press release Friday.

"Today's actions make clear that the Biden-Harris Administration will not give student loan servicers a free pass for poor performance and missteps that jeopardize borrowers," U.S. Secretary of Education Miguel Cardona said in the release.

The DOE said 758,000 borrowers from the three companies were affected when they did not receive timely notice of their bills.

In response to the errors, the DOE has withheld $2 million from Aidvantage, $161,000 from EdFinancial and $13,000 from Nelnet, in proportion to how many borrowers were affected.

The companies have been ordered to place affected borrowers in administrative forbearance, which means they will not owe payments until the issue is resolved.

The loans will be set at near 0% interest while in administrative forbearance and the months spent in forbearance will count toward Public Service Loan Forgiveness.

"We are committed to providing a seamless repayment experience for borrowers," said Federal Student Aid Chief Operating Officer Rich Cordray.

https://www.marketscreener.com/quote/stock/NELNET-INC-13757/news/Biden-Administration-withholds-funds-from-noncompliant-student-loan-lenders-45683784/

Gentex eSight Acquisition Set to Showcase Advanced Vision Tech at CES

 Gentex Corporation (NASDAQ: GNTX) announced today the asset acquisition of eSight, a leading provider of vision enhancement technologies, to develop and manufacture the next generation of mobile electronic eyewear designed to help people living with visual impairments. Gentex will prominently feature eSight’s next-gen technology at the Consumer Electronics Show (CES) 2024.

Gentex is a technology company and a long-time supplier of electro-optical products for the global automotive, aerospace, and fire protection industries. It is best known for supplying nearly every major automaker with connected-car technologies and advanced electronic features that optimize driver vision and enhance driving safety.

eSight is a wearable assistive technology that allows people living with visual impairments to stay on the go while performing the tasks of daily living. The comprehensive medical equipment enhances vision for individuals with over 20 distinct ocular disorders, frequently enabling users to attain 20/20 vision. eSight eyewear combines a high-definition camera, proprietary algorithms, and powerful processing platform to relay and magnify real-time imagery onto two high-resolution screens positioned before each eye, resulting in enhanced binocular vision.

https://www.globenewswire.com/news-release/2024/01/07/2805000/32299/en/Gentex-Announces-eSight-Acquisition-Set-to-Showcase-Advanced-Vision-Tech-at-CES-2024.html

Qiagen to return approximately $300 million to shareholders

 

Capital return to be conducted through synthetic share repurchase // Return of up to $300 million – maximum approved by shareholders in 2023 – designed to enable efficient return of cash to shareholders and enhance EPS // Implementation planned to be completed in late January 2024

Ascendis, Specialised Therapies in pact on endocrinology therapies

 

  • Agreement between Ascendis Pharma A/S and ST is for the exclusive distribution and commercialisation of three Ascendis Pharma endocrinology therapies
  • Two of the therapies are already internationally approved, the third is in development following successful Phase 2 data
  • ST's exclusive distribution agreement covers AustraliaNew ZealandSingaporeMalaysiaBruneiThailand and Vietnam

Paxlovid Does Not Reduce Risk Of Long COVID, Potentially Linked To Rebound Symptoms: Study

by Amie Dahnke via The Epoch Times (Emphasis ours),

Paxlovid, an antiviral medication prescribed to treat symptoms associated with COVID-19, does not reduce the risk of developing long COVID in vaccinated people recovering at home.

The report comes from a new study published in the Journal of Medical Virology on Thursday. Conducted by a team of researchers from the University of California–San Francisco, the study also found that more people are experiencing rebounds of their COVID symptoms after taking Paxlovid (nirmatrelvir-ritonavir) than previously reported.

Paxlovid is the first antiviral pill approved by the U.S. Food and Drug Administration (FDA) to treat mild and moderate COVID-19 in adults. It is typically prescribed to those at high risk of having the virus progress to a severe illness, including hospitalization or death. The medication has also been authorized for use in children 12 and older who are at risk of severe outcomes from COVID-19.

According to manufacturer Pfizer, initial trials of Paxlovid showed it reduced hospitalizations and death in unvaccinated COVID patients by 86 percent to 89 percent. A real-world study conducted by the U.S. Centers for Disease Control and Prevention (CDC) showed that adults who took Paxlovid within the first five days of a COVID-19 diagnosis had a 51 percent lower hospitalization rate within 30 days than those who did not take the medication. More recent studies have indicated lower efficacy rates, with patients having about 37 percent reduced hospitalization and death risk.

However, no study has pointed to whether the drug helps protect people from getting long COVID, noted authors of the UC San Francisco study.

Paxlovid Did Not Prevent Long COVID

To determine if Paxlovid protects against long COVID, the research team examined over 4,600 vaccinated individuals from the UC San Fransisco COVID-19 Citizen Science study who experienced their first positive COVID-19 tests between March and August 2022. None of the patients was hospitalized. About 20 percent of patients took the three-pill course of Paxlovid, while about 80 percent did not.

In December 2022, the patients answered a follow-up survey that included questions about long COVID, COVID rebound symptoms, and how long they continued to test positive.

“We found a higher proportion with clinical rebound than previously reported, but did not identify an effect of posttreatment rebound on Long COVID symptoms,” researchers wrote.

The team found little difference between the two groups. For example, roughly 16 percent of patients prescribed Paxlovid had long-COVID symptoms compared to about 14 percent who were not prescribed the medication. Long-COVID patients in each group experienced fatigue, shortness of breath, confusion, headache, and changes in sense of smell and taste.

Paxlovid Rebound Symptoms Confirmed

The UC San Francisco study reported that just over 1 in 5 individuals (21 percent) who reported getting better after taking Paxlovid experienced rebound symptoms, or a return of their COVID symptoms. Among those who experienced rebounds, 10.8 percent reported one or more long-COVID symptoms.

Additionally, retesting positive was common among rebound patients; 25.7 percent of individuals who took Paxlovid and repeated antigen testing after testing negative ended up testing positive.

In all, just over 26 percent of participants reported either rebound symptoms or test positivity, the study noted.

Of the roughly 75 percent who didn’t experience rebound while on Paxlovid, 8.3 percent reported at least one long-COVID symptom.

The study echoes a Nov. 13, 2023, study conducted by Harvard Medical School (HMS) researchers also indicating that 1 in 5 individuals who took Paxlovid experienced a rebound of symptoms.

“We conducted this study to address lingering questions about Paxlovid and virologic rebound in COVID-19 treatment,” senior author Dr. Mark Siedner, associate professor of medicine at HMS and an infectious disease clinician and researcher at Massachusetts General Hospital, said in a HMS press release. “We found that the virologic rebound phenomenon was much more common than expected—in over 20 percent of people taking Paxlovid—and that individuals shed live virus when experiencing a rebound, which means they may be contagious after initial recovery.”

Previous clinical trials suggested that between 1 percent and 2 percent of patients who took Paxlovid experienced rebound, according to the press release.

https://www.zerohedge.com/political/paxlovid-does-not-reduce-risk-long-covid-potentially-linked-rebound-symptoms-study

EU Adopts "Emergency Airworthiness Directive" After FAA Grounds Boeing 737-9 Max Jets

 Shortly after the US Federal Aviation Administration issued an emergency order to ground 171 Boeing 737-9 (MAX) jets used by major airlines due to an incident where an emergency door separated from an Alaska Airlines Max jet over Portland on Friday evening, European aviation authorities have adopted the FAA's directive.

EASA wrote in a statement that "specific configuration" of the 737-9 MAX aircraft will be grounded for immediate inspection following "an event on an Alaska Airlines flight, where an exit panel detached from the aircraft inflight, leading to rapid decompression of the cabin." 

"EASA took the decision to adopt the FAA Emergency Airworthiness Directive (EAD) despite the fact that, to the Agency's knowledge and also on the basis of statements from the FAA and Boeing," the regulator said. 

However, the EU regulator noted, "No airline in an EASA Member State currently operates an aircraft in the relevant configuration." 

Safety precautions in the EU for the troubled 737 MAX come as the FAA grounded 171 737-9 Max jets on Saturday after a mid-cabin exit door on an Alaska Airlines flight separated from the plane mid-flight over Portland.  

Here's a list of the latest actions by airlines in the US and worldwide that operate these troubled jets (list courtesy of Bloomberg): 

  • Alaska Air Group Inc., the airline at the center of the turmoil, initially grounded all 65 of its 737-9 Max jets hours after the accident. It later allowed 18 of the planes to resume flying after receiving detailed maintenance inspections pre- dating the event. However, it subsequently pulled all jets from service again.
  • United Airlines Holding Inc., the biggest operator of the affected Max type, says all 79 of its jets are temporarily grounded. The next step is for the airline to determine with the FAA the inspection process and requirements to return the planes to service. It earlier said 33 of the jets had met necessary inspections before grounding all planes.
  • Panama's Copa Airlines SA said it grounded 21 of its impacted jets. The carrier has a total of 29 in its fleet, but operates them in two different configurations. - Aeromexico has followed United and Alaska Air in pulling all 19 of its 737-9 Max jets from service for inspections.
  • Icelandair said its small fleet of 737-9 Max jets are not affected by FAA inspections. The carrier has been in contact with Boeing and the FAA.
  • Turkish Airlines said its country's civil aviation authority asked it to examine its small fleet of five 737-9 Max planes. Until the technical review is complete, the carrier has withdrawn the jets from service.
  • FlyDubai said its three 737-9 Max jets are unaffected by the FAA directive, the company told Bloomberg News.

One X user wrote:

The Boeing 737 Max hull failure is bad This was a brand-new aircraft. ~150 revenue flights. Probably no more than 250 pressurization cycles on it total (if that) While failures of this sort are not unknown, they tend not to occur on a new airframe. Which suggests that a production issue is at fault...

Remember this... 

We suspect Boeing shares might be red come Monday morning. 

https://www.zerohedge.com/markets/eu-adopts-emergency-airworthiness-directive-after-faa-grounds-boeing-737-9-max-jets-over